Lantern Pharma Says AI Cuts First-In-Human Drug Development Cost To $2 Million-$3 Million - Pulse 2.0

An AI company claims it can reduce early-stage drug development costs from tens of millions to just $2-3 million, potentially making new medicines faster and cheaper to develop. This could speed up treatments reaching patients.